Nomad Foods Limited (NOMD) is Europe’s leading frozen food company, with brands including Birds Eye, Iglo, and Findus. Its quarterly earnings are closely watched because the business has spent recent years navigating elevated input costs, particularly in fish, while working to rebuild volumes and market share against private-label competition. The third-quarter 2026 report carries extra weight because it marks the first return to organic revenue growth after earlier declines. For investors, the results offer a read on whether pricing actions are sticking, whether cost inflation is easing, and whether the company’s cash generation and dividend remain durable amid ongoing margin pressure. In my view, this stabilization is a key signal worth monitoring.
Nomad Foods reports in euros. For the third quarter ended September 30, 2026, the company posted revenue of €770.0 million, an increase of roughly 2.3% from €752.4 million in the same period a year earlier. Basic and diluted EPS came in at €0.48, up from €0.39 a year ago.
On a U.S.-dollar basis, adjusted EPS of about $0.48 modestly exceeded the consensus estimate of roughly $0.47, while reported revenue also came in slightly ahead of expectations. The headline driver was a 1.6% return to organic revenue growth, with retail sell-out growing approximately 1% and volumes essentially stable at -0.2%. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Profitability remained under pressure from inflation and the normalization of incentive compensation, but cash generation was a bright spot. Year-to-date adjusted free cash flow (FCF) rose 22% to €80 million from €66 million a year earlier, helped by improved working capital management and lower cash tax and interest costs.
Heading into the print, investor attention was centered on whether Nomad Foods could finally stabilize volumes and reignite organic growth after a stretch of declines. The confirmation of a return to growth, combined with reiterated guidance and stronger cash conversion, provides a more constructive backdrop for sentiment. Analysts have generally maintained a Buy-equivalent consensus rating, with price targets in the low-to-mid teens, while the stock’s dividend and free cash flow yields remain points of support for income-oriented investors. Risks that could temper enthusiasm include continued fish-cost inflation, uncertainty around a second off-cycle price increase in the fourth quarter, and execution in fast-growing discount channels.
Management reiterated its full-year 2026 guidance, which includes an organic revenue outlook of -2% to -3% and an adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) decline of 5% to 10%. Adjusted EPS is expected in the range of €1.38 to €1.53, with adjusted free cash flow conversion above 90%.
The fourth quarter carries a wider range of outcomes. Management pointed to additional inflation, particularly in fish input costs, and to variability around customer response to a second off-cycle price increase and the timing of shipments. These factors will be central to whether the company can hold the top end of its guidance.
Looking further ahead, the company reaffirmed its 2027 targets of 0% to 2% organic revenue growth and 0% to 2% adjusted EBITDA growth, with free cash flow conversion again above 90%. At the midpoint, that would mark a return to both top-line and bottom-line growth. Investors should monitor cost trends, pricing execution, the expansion of the European discount channel, and any lingering supply-chain disruptions following recent cyberattacks on freezer systems in parts of Europe. From what I see, this is important because it sets the stage for potential recovery.
When evaluating results like these, I frequently rely on Tickeron’s AI Screener to quickly filter peers and spot patterns in fundamentals or technicals that might otherwise take hours to review manually. It helps me cross-check industry positioning and identify comparable names with similar growth profiles, which adds useful context to the earnings picture without replacing deeper fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for NOMD turned positive on October 02, 2026. Looking at past instances where NOMD's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on NOMD as a result. In 49 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
NOMD moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NOMD crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +3.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOMD advanced for three days, in 166 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Aroon Indicator entered an Uptrend today. In 117 of 198 cases where NOMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
NOMD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. NOMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.680) is normal, around the industry mean (5.975). P/E Ratio (14.080) is within average values for comparable stocks, (7.223). Projected Growth (PEG Ratio) (0.650) is also within normal values, averaging (8.458). Dividend Yield (0.056) settles around the average of (0.048) among similar stocks. P/S Ratio (0.462) is also within normal values, averaging (5.003).
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company which produces frozen foods
Industry FoodMajorDiversified